Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV001199439 | SCV001162422 | pathogenic | Retinitis pigmentosa | 2020-01-09 | criteria provided, single submitter | research | |
Blueprint Genetics | RCV001073390 | SCV001238931 | uncertain significance | Retinal dystrophy | 2019-01-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002549225 | SCV003024277 | uncertain significance | Bardet-Biedl syndrome | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 13 of the BBS4 gene. It does not directly change the encoded amino acid sequence of the BBS4 protein. This variant is present in population databases (rs770577174, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with BBS4-related conditions. ClinVar contains an entry for this variant (Variation ID: 813022). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |